Methyl carbazate → HCID 69982559, compound
Reaction equation
O=[C:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:13]=[CH:12][C:11]([N:14]3[CH2:18][C@H:17]([CH2:19][O:20][C:21]4[CH:25]=[CH:24][O:23][N:22]=4)[O:16][C:15]3=[O:26])=[CH:10][C:9]=2[F:27])[CH2:4][CH2:3]1.[C:28]([O:32][CH3:33])(=[O:31])[NH:29][NH2:30]>CO.ClCCl>[CH3:33][O:32][C:28]([NH:29][N:30]=[C:2]1[CH2:3][CH2:4][N:5]([C:8]2[CH:13]=[CH:12][C:11]([N:14]3[CH2:18][C@H:17]([CH2:19][O:20][C:21]4[CH:25]=[CH:24][O:23][N:22]=4)[O:16][C:15]3=[O:26])=[CH:10][C:9]=2[F:27])[CH2:6][CH2:7]1)=[O:31]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
3-(4-(4-Oxopiperidin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one (125 mg, 0.33 mmol) was dissolved in MeOH (5 ml) and dichloromethane (5 ml), methyl carbazate (34 mg, 0.37 mmol) added, and the mixture stirred at ambient temperature under nitrogen for 18 hours. The mixture was evaporated, and the residue purified by chromatography on a 5 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 1% MeOH in dichloromethane. Relevant fractions were combined to give the desired product (98 mg).
Workup
- customThe mixture was evaporated
- customthe residue purified by chromatography on a 5 g silica Mega Bond Elut® column
- washeluting with a gradient
- temperatureincreasing in polarity from 0 to 1% MeOH in dichloromethane
Sources & evidence
- ORD record
- ord-eb6d5c65b6de43f297d7029106379fa1
- Source dataset
- uspto-grants-2003_09
- Patent number
- US06617339B1
Reaction notes
Loading…